[1]
McMahon DE, Kovarik CL, Damsky W, et al. Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study. J Am Acad Dermatol 2022; 86(1): 113-21.
[http://dx.doi.org/10.1016/j.jaad.2021.09.002] [PMID: 34517079]
[http://dx.doi.org/10.1016/j.jaad.2021.09.002] [PMID: 34517079]
[2]
Sadeghi S, Kalantari Y, Shokri S, et al. Immunologic response, efficacy, and safety of vaccines against COVID-19 infection in healthy and immunosuppressed children and adolescents aged 2 - 21 years old: A systematic review and meta-analysis. J Clin Virol 2022; 153: 105196.
[http://dx.doi.org/10.1016/j.jcv.2022.105196] [PMID: 35716417]
[http://dx.doi.org/10.1016/j.jcv.2022.105196] [PMID: 35716417]
[3]
Sadeghi S, Amini Z, Goodarzi A. A comparative review on mucocutaneous reactions caused by Covid‐19 infection versus Covid‐19 vaccination. Exp Dermatol 2022; 31(8): exd.14620.
[http://dx.doi.org/10.1111/exd.14620] [PMID: 35657119]
[http://dx.doi.org/10.1111/exd.14620] [PMID: 35657119]
[4]
Xia S, Zhang Y, Wang Y, et al. Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial. Lancet Infect Dis 2022; 22(2): 196-208.
[http://dx.doi.org/10.1016/S1473-3099(21)00462-X] [PMID: 34536349] [PMCID: PMC8443232]
[http://dx.doi.org/10.1016/S1473-3099(21)00462-X] [PMID: 34536349] [PMCID: PMC8443232]
[5]
Walter EB, Talaat KR, Sabharwal C, et al. Evaluation of the BNT162b2 Covid-19 vaccine in children 5 to 11 years of age. N Engl J Med 2022; 386(1): 35-46.
[http://dx.doi.org/10.1056/NEJMoa2116298] [PMID: 34752019]
[http://dx.doi.org/10.1056/NEJMoa2116298] [PMID: 34752019]
[6]
Godfred-Cato S, Bryant B, Leung J, et al. COVID-19-associated multisystem inflammatory syndrome in children-United States, March-July 2020. MMWR Morb Mortal Wkly Rep 2020; 69(32): 1074-80.
[http://dx.doi.org/10.15585/mmwr.mm6932e2] [PMID: 32790663]
[http://dx.doi.org/10.15585/mmwr.mm6932e2] [PMID: 32790663]
[7]
Yousaf AR, Cortese MM, Taylor AW, et al. Reported cases of multisystem inflammatory syndrome in children aged 12-20 years in the USA who received a COVID-19 vaccine, December, 2020, through August, 2021: a surveillance investigation. Lancet Child Adolesc Health 2022; 6(5): 303-12.
[http://dx.doi.org/10.1016/S2352-4642(22)00028-1] [PMID: 35216660]
[http://dx.doi.org/10.1016/S2352-4642(22)00028-1] [PMID: 35216660]
[8]
Peralta-Amaro AL, Tejada-Ruiz MI, Rivera-Alvarado KL, et al. Atypical Kawasaki disease after COVID-19 vaccination: A new form of adverse event following immunization. Vaccines 2022; 10(1): 126.
[http://dx.doi.org/10.3390/vaccines10010126] [PMID: 35062787]
[http://dx.doi.org/10.3390/vaccines10010126] [PMID: 35062787]
[9]
Niebel D, Wenzel J, Wilsmann-Theis D, Ziob J, Wilhelmi J, Braegelmann C. Single-center clinico-pathological case study of 19 patients with cutaneous adverse reactions following COVID-19 vaccines. Dermatopathology 2021; 8(4): 463-76.
[http://dx.doi.org/10.3390/dermatopathology8040049] [PMID: 34698094]
[http://dx.doi.org/10.3390/dermatopathology8040049] [PMID: 34698094]
[10]
Haslak F, Gunalp A, Cebi MN, et al. Early experience of COVID‐19 vaccine‐related adverse events among adolescents and young adults with rheumatic diseases: A single‐center study. Int J Rheum Dis 2022; 25(3): 353-63.
[http://dx.doi.org/10.1111/1756-185X.14279] [PMID: 34978376]
[http://dx.doi.org/10.1111/1756-185X.14279] [PMID: 34978376]
Related Books
Common Pediatric Diseases: an Updated Review
